Sale of 1,590 shares at $80 per share.
Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001842190-26-000009 · filed 2026-09-03 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Tarsus Pharmaceuticals, Inc. (TARS)." Disclosed 2026-09-03. https://desqlong.com/cards/0001842190-26-000009-3 (retrieved 2026-09-26).